Global Fund get $9.7B pledges for 2008

7 October 2007

Donors meeting in Berlin, Germany, have provided initial pledges to the Global Fund to Fight AIDS, Tuberculosis and Malaria worth $9.7 billion over three years, the group has announced. The pledges constitute the largest single financing exercise for health ever, allowing the Global Fund to move towards annual commitments of $6.0 billion to $8.0 billion by 2010.

The chairman of the Global Fund's Replenishment Mechanism and former United Nations Secretary General, Kofi Annan, said: "with these new resource pledges, the global community has taken a significant step towards achieving the goals we have set for fighting these diseases."

The donor meeting was hosted by the German federal government and was opened by Chancellor Angela Merkel. Germany's Development Minister, Heidemarie Wieczorek-Zeul, noted that the country had doubled its annual contributions.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight